Amisulpride

(Barhemsys®)

Amisulpride

Drug updated on 11/14/2023

Dosage FormInjection (intravenous: 5 mg/2 mL, 10 mg/4 mL)
Drug ClassDopamine-2 antagonists
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated in adults for prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
  • Indicated in adults for treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.